Shigeaki Morooka

Title: Shigeaki Morooka: Innovator in Mammalian Receptor Research

Introduction

Shigeaki Morooka is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of mammalian receptors. His work has implications for understanding various physiological processes and potential therapeutic applications.

Latest Patents

Morooka holds a patent for the "Mammalian ICYP (iodocyanopindolol) receptor and its applications." This invention describes an isolated and substantially pure mammalian polypeptide that differs from known adrenergic, serotonin, and dopamine receptors. The polypeptide is found on mammalian muscle and eosinophil membranes, including those of rats, guinea pigs, and humans. The patent also covers plasmids containing the genes coding for this polypeptide, host cells transformed by these genes, nucleotide probes for hybridization, and antibodies directed against the polypeptide. The polypeptide is characterized by its ability to bind iodocyanopindolol (ICYP) and has specific molecular weight properties when analyzed through various techniques.

Career Highlights

Morooka is associated with Dainippon Sumitomo Pharma Co., Ltd., where he continues to advance research in pharmacology and receptor biology. His innovative work has led to a deeper understanding of non-adrenergic receptors and their potential roles in various biological systems.

Collaborations

Throughout his career, Morooka has collaborated with esteemed colleagues such as Gerlinde Lenzen and Arthur Donny Strosberg. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Shigeaki Morooka's contributions to the field of mammalian receptor research highlight his role as a significant inventor. His patent on the ICYP receptor opens new avenues for understanding receptor biology and developing therapeutic strategies.